# US 2010/0167386 A1 · Immunosensor system for blood with reduced interference

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167386 A1
- Document ID: US20100167386A1
- Status: Published application
- Kind: A1
- Application number: 12/708,458
- Filed: 2010-02-18
- Published: 2010-07-01
- Earliest claimed: 2003-09-10
- Assignees: Abbott Point of Care Inc.
- Inventors: Cary James Miller; John Lewis Emerson Campbell
- Web page: https://patentgrep.com/patent/US20100167386A1

## CPC

- G01N 33/5438: {Electrodes}
- Y10S 436/807: Apparatus included in process claim, e.g. physical support structures
- Y10T 436/25: including sample preparation
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

An electrochemical immunosensor system with reduced interference, comprising: a first immunosensor that generates an electrochemical signal based on the formation of a sandwich between an immobilized antibody, a target analyte and a labeled antibody, wherein a portion of the signal arises from non-specific binding of the labeled antibody in the region of the first immunosensor, and a second immunosensor that acts as an immuno-reference sensor and generates a signal that is the same as or predictably related to the degree of non-specific binding which occurs in the region of the first immunosensor, and has an immunocomplex between an immobilized antibody and an endogenous or exogenous protein that is in the sample and that is not the target analyte.

## Claims

### Claim at position 1

1-68. (canceled)

### Claim 69

An immunosensor system for blood with reduced interference, comprising:
an immunosensor for blood samples that generates a signal based on the formation of a sandwich between a first immobilized antibody to a target analyte, the target analyte, and a labeled antibody,
wherein the sensing surface of said immunosensor contains a second immobilized antibody covering at least a portion thereof that forms an immunocomplex between an endogenous or exogenous protein that is in the sample and that is not the target analyte.

### Claim 70 (depends on 69)

The immunosensor system of claim 69, wherein the immunosensor is an electrochemical sensor.

### Claim 71 (depends on 69)

The immunosensor system of claim 69, wherein the immunosensor is an amperometric electrochemical sensor.

### Claim 72 (depends on 69)

The immunosensor system of claim 69, wherein the immunosensor is selected from the group consisting of potentiometric sensors, field effect transistor sensors, conductimetric sensors, optical sensors, evanescent wave sensors, optical wave guides, thermometric sensors and acoustic wave sensors.

### Claim 73 (depends on 69)

The immunosensor system of claim 69, which is in a disposable cartridge for measuring analytes in a sample.

### Claim 74 (depends on 69)

The immunosensor system of claim 69, wherein the target analyte is selected from the group consisting of troponin I, troponin T, creatine kinase MB, procalcitonin, hCG, BNP, proBNP, NTproBNP and myoglobin.

### Claim 75 (depends on 69)

The immunosensor system of claim 69, wherein the second immobilized antibody is to a plasma protein.

### Claim 76 (depends on 69)

The immunosensor system of claim 69, wherein the second immobilized antibody is to a protein selected from the group consisting of human serum albumin (HAS), bovine serum albumin (BSA), fibrinogen and IgG fc region.

### Claim 77 (depends on 69)

The immunosensor system of claim 69, wherein the second immobilized antibody has an affinity constant of about 1×10−7 to about 1×10−15 M.

### Claim 78 (depends on 69)

The immunosensor system of claim 69, wherein both antibodies are immobilized on microparticles of diameter in the range 0.01 μm -5.0 μm.

### Claim 79 (depends on 69)

The immunosensor system of claim 69, wherein the endogenous or exogenous protein is present in a blood sample at a concentration of at least three orders of magnitude above the affinity constant of the second antibody.

### Claim 80 (depends on 69)

The immunosensor system of claim 69, further comprising a bulk conductivity sensor and computation means for processing signals from the immunosensor and the conductivity sensor to correct for the hematocrit of the sample and determine the equivalent plasma analyte concentration.

### Claim 81 (depends on 69)

The immunosensor system of claim 69, wherein a blood sample is treated to reduce interference associated with leukocytes by adding a salt reagent to increase the ionic strength of the sample to at least 200 mM sodium.
